Open AccessS208 RBX2660, an Investigational Live Microbiota-based Biotherapeutic, Improves Outcomes of Clostridioides difficile Infection in a Real-World Population: A Retrospective Study of Use Under Enforcement Discretion
Author(s) -
Paul Feuerstadt,
Adam Harvey,
Lindy Bancke
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000773304.23885.43
Subject(s) - medicine , population , retrospective cohort study , ulcerative colitis , concomitant , medical record , inflammatory bowel disease , clinical trial , adverse effect , disease , environmental health